Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The record history view was updated to include a newer submitted/revision entry (and corresponding UI revision version). This indicates an additional study history update affecting sections like Contacts/Locations and Study Status, rather than a major change to the core study description or outcomes.
    Difference
    0.3%
    Check dated 2026-04-24T05:56:07.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision history shows an update from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:24.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:09:16.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces Revision: v3.4.2 in the page history.
    Difference
    0.1%
    Check dated 2026-03-11T20:21:39.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.4.2) to the record history. Removed the older government-funding notice and revision v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T01:52:33.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the new revision tag v3.4.1. Removed the previous revision tag v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T00:41:51.000Z thumbnail image

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.